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To the Editor: Methicillin-resist-
ant Staphylococcus aureus (MRSA) is
an established nosocomial pathogen
worldwide but more recently has
emerged as a highly virulent organism
in the community, particularly in the
United States (1–3). In Latin America,
community-associated MRSA (CA-
MRSA) has only been described in
the southern area of the continent
(Uruguay and Brazil) (4,5). No
reports from the Andean region are
available. We describe 2 cases of CA-
MRSA causing soft-tissue infections
(1 severe) in Colombia. 
The first case was in a 19-year-old
man with a history of trauma to the
left side of his body 1 week before
admission after a fall. On admission,
he complained of 2 days of fever,
malaise, erythema and induration in
the left hemithorax extending to the
left thigh, and purulent secretion from
an excoriation on the anterior aspect
of the left thigh. He had no previous
medical history. No previous hospital-
izations or antimicrobial drug pre-
scriptions were documented, nor did
he report relatives with history of
recent hospitalizations. Vital signs at
admission were normal except for
fever (39°C), and physical examina-
tion showed induration and erythema
in the region of left hemithorax
extending to the thigh, with an area of
excoriation in the same thigh with
purulent discharge. Laboratory evalu-
ation showed a leukocyte count of
23.1×109/L (86% neutrophils with 2%
band forms) and elevated C-reactive
protein levels. 
The patient was hospitalized.
Because necrotizing fascitis was sus-
pected, intravenous ampicillin-sul-
bactam (12 g per day) was started, and
surgical evaluation was requested.
The patient underwent surgical
debridement of the left thigh, left
hemiabdomen, and hemithorax,
which confirmed the diagnosis of
necrotizing fascitis. Intravenous van-
comycin (1 g every 12 h) was added
to the regimen, and the patient was
transferred to the intensive care unit.
After several surgical debridements,
the patient underwent placement of
cutaneous-muscle grafts. He was dis-
charged from the hospital without
complications after completing 14
days of antimicrobial agents.
The second case involved a 53-
year-old man with no history of pre-
vious hospitalizations who reported
to the emergency department with a
3-day history of fever, pain, swelling,
and warm sensation on the posterior
aspect of the left thigh. A diagnosis of
cellulitis was made, and cephalexin
(500 mg every 6 h) and gentamicin
(160 mg intramuscularly every 24 h)
were administered for 7 days without
improvement. He returned to the hos-
pital with worsening symptoms, an
area of induration of 4×4 cm in the
thigh, and purulent discharge.
Drainage of the lesion was per-
formed, and oral trimethoprim and
sulfamethoxazole (160 and 800 mg,
respectively, every 12 h) was started.
His clinical signs and symptoms
completely resolved after 7 days of
therapy.
Tissue culture from secretions
from both patients showed gram-pos-
itive cocci in clusters on the Gram
stain, and subsequent cultures yielded
MRSA. Species identification and
presence of the mecA gene were con-
firmed by PCR, as described previ-
ously (6). MICs were determined by
using the agar diffusion test, accord-
ing to Clinical and Laboratory
Standards Institute recommendations
(7). Both organisms were susceptible
to vancomycin, teicoplanin, chloram-
phenicol, linezolid, ciprofloxacin,
gentamicin, and rifampin. The isolate
from the second patient was resistant
to erythromycin and susceptible to
clindamycin, exhibited the M pheno-
type on the double-disk diffusion
assay (D test), and harbored the msrA
gene, encoding an efflux pump (8). In
contrast, the first isolate was suscepti-
ble to both erythromycin and clin-
damycin and resistant to tetracycline
(MIC >64 µg/mL). Because infec-
tions caused by CA-MRSA isolated
elsewhere are associated with the
presence of the lukF gene encoding
the Panton-Valentine leukocidin toxin
and the staphylococcal chromosome
cassette mec (SCCmec) type IV, the
presence of both was evaluated by
PCR, as described previously (9).
Both isolates were positive for lukF
and harbored the SCCmec type IV.
The molecular epidemiology of
healthcare-related MRSA in
Colombia has changed during the past
3 years (10), but no reports of CA-
MRSA had emerged. We believe these
to be the first reports of CA-MRSA in
Colombia with similar characteristics
to those reported elsewhere. No risk
factors associated with healthcare-
associated MRSA were found in
either of these patients, and the
patients were not epidemiologically
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related. The first case involved a
severe soft-tissue infection associated
with CA-MRSA. Clinicians should be
aware of the circulation of CA-MRSA
in Colombia.
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Live Nativity and
Brucellosis, Sicily 
To the Editor: Worldwide, brucel-
losis remains a major zoonosis and an
important cause of travel-associated
illness (1). Brucellosis is transmitted
to humans through the consumption
of infected, unpasteurized, animal-
milk products; direct contact with
infected animal parts; or inhalation of
infected aerosolized particles. We
report an outbreak of brucellosis in a
small village of the Ionic coast of
Messina province (eastern Sicily).
In 2003, health authorities in the
Messina province were notified of 29
cases of brucellosis; 18 of the patients
were members of 9 different families.
All patients had observed a Nativity
pantomime that used live animals and
was organized by the local popula-
tion. Nativities in Sicily last ≈1
month, during which the sheep are
milked, cheese and ricotta are pro-
duced, and these products are sold or
offered fresh to tourists. All 29
patients had consumed dairy prod-
ucts: tuma cheese by 29 (100%) and
tuma and ricotta by 16 (55%). No
other risk factors for brucellosis were
reported. Symptoms appeared after a
median of 45 days (range 30–70).
Eight patients were children (3 male),
and 21 were adults (10 male). The
median age of the children was 10.5
years (range 6–13) and of the adults,
42 years (range 16–67).
Hospitalization was required for 5
patients. For 2 adults, brucellosis was
complicated by spondylitis.
The real extent of the outbreak was
likely large because in Sicily ≈60% of
cases may go unreported. Further-
more, we report only the cases that
occurred in the villages of Messina
province and that were reported to
health authorities; but tourists from
many other areas in Italy and some
from outside Italy generally attend
such events. Southern Italy has com-
monly been implicated as a venue for
travel-associated brucellosis (2).
In Italy, the overall incidence of
brucellosis has gradually declined in
the past 30 years, especially in north-
ern Italy, where the disease is now
reported only sporadically. This trend,
however, has led to an increase in the
percentage of total cases in Italians
reported from the southern provinces
of Calabria, Campagna, Puglia, and
Sicily; of the 520 cases reported in
2003, 488 (93.8%) were reported
from 4 southern regions, compared
with 63.7% in 1994. Sicily alone
reported 57.6% of the 2003 cases and
for the past decade has had an average
annual incidence of >100 cases per
million (1,3). The disease is almost
always caused by Brucella melitensis
(4). The southern localization of the
disease in Italy is obviously related to
the relative high prevalence of infec-
tions in sheep and goats (5). Ovine
and caprine population density is
higher in the southern regions of Italy
than in the rest of the country (6).
The Italian brucellosis eradication
plan consists of a test-and-slaughter
practice. However, in Sicily a vacci-
nation campaign with B. melitensis
Rev.1 strain has been started. In 2003,
≈99% of the stock farms were tested,
and ≈18% of them were infected (3).
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 12, December 2006 2001
